Effects of GLP-1 on gastric emptying, antropyloric motility, and transpyloric flow in response to a nonnutrient liquid
- PMID: 9635598
- DOI: 10.1023/a:1018863716749
Effects of GLP-1 on gastric emptying, antropyloric motility, and transpyloric flow in response to a nonnutrient liquid
Abstract
Glucagon-like polypeptide 1 (GLP-1) may be a major enterogastrone, slowing gastric emptying when released by intestinal nutrients. In six conscious dogs, we studied the effects of GLP-1, on antropyloric motility, gastric emptying, and transpyloric flow after instillation of 500 ml of saline into the stomach. The meal was given and recordings were started 15 min after intravenous bolus and infusion of either saline or three different doses of GLP-1. Intravenous GLP-1 produced a dose-related retardation of gastric emptying associated with a decrease in the number and volume of flow pulses in comparison to saline. This change in transpyloric flow was associated with an inhibition of antropyloric pressure waves, a stimulation of isolated pyloric pressure waves, and an increase in basal pyloric tone induced by intravenous GLP-1 infusion. Our findings show that GLP-1 has a potent dose-dependent inhibitory effect on transpyloric flow and gastric emptying. This effect is temporally associated with inhibition of antral "pumping" and stimulation of pyloric "braking" mechanisms.
Similar articles
-
Role of nitric oxide mechanisms in control of pyloric motility and transpyloric flow of liquids in conscious dogs.Dig Dis Sci. 1998 Mar;43(3):506-12. doi: 10.1023/a:1018898621465. Dig Dis Sci. 1998. PMID: 9539644
-
Effects of glucagon-like peptide-1(7-36)amide on antro-pyloro-duodenal motility in the interdigestive state and with duodenal lipid perfusion in humans.Gut. 2000 May;46(5):622-31. doi: 10.1136/gut.46.5.622. Gut. 2000. PMID: 10764704 Free PMC article.
-
Glucagon-like peptide-2 inhibits antral emptying in man, but is not as potent as glucagon-like peptide-1.Scand J Gastroenterol. 2004 Apr;39(4):353-8. doi: 10.1080/00365520410004424. Scand J Gastroenterol. 2004. PMID: 15125467 Clinical Trial.
-
Is glucagon-like peptide 1 an incretin hormone?Diabetologia. 1999 Mar;42(3):373-9. doi: 10.1007/s001250051165. Diabetologia. 1999. PMID: 10096792 Review.
-
GLP-1 in NIDDM.Diabet Med. 1996 Sep;13(9 Suppl 6):S156-60. Diabet Med. 1996. PMID: 8894501 Review.
Cited by
-
Effects of glucagon-like peptide-1(7-36)amide on motility and sensation of the proximal stomach in humans.Gut. 2002 Mar;50(3):341-8. doi: 10.1136/gut.50.3.341. Gut. 2002. PMID: 11839712 Free PMC article. Clinical Trial.
-
Gut Hormones and Inflammatory Bowel Disease.Biomolecules. 2025 Jul 14;15(7):1013. doi: 10.3390/biom15071013. Biomolecules. 2025. PMID: 40723884 Free PMC article. Review.
-
Endogenous glucagon-like peptide 1 controls endocrine pancreatic secretion and antro-pyloro-duodenal motility in humans.Gut. 2006 Feb;55(2):243-51. doi: 10.1136/gut.2004.059741. Epub 2005 Jun 28. Gut. 2006. PMID: 15985560 Free PMC article.
-
Advances in the physiology of gastric emptying.Neurogastroenterol Motil. 2019 Apr;31(4):e13546. doi: 10.1111/nmo.13546. Epub 2019 Feb 10. Neurogastroenterol Motil. 2019. PMID: 30740834 Free PMC article. Review.
-
Glucagon-like peptide-1 modulates neurally evoked mucosal chloride secretion in guinea pig small intestine in vitro.Am J Physiol Gastrointest Liver Physiol. 2012 Feb 1;302(3):G352-8. doi: 10.1152/ajpgi.00333.2011. Epub 2011 Nov 10. Am J Physiol Gastrointest Liver Physiol. 2012. PMID: 22075777 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources